Skip to main content

Table 3 Demographic, clinical, biochemical and angiographic characteristics in low and high SYNTAX score II group

From: The relationship between IL-6 levels and the angiographic severity of coronary artery disease following percutaneous coronary intervention in acute coronary syndrome patients

Variables SS II ≤ 25.4 (n = 100) SS II > 25.4 (n = 101) P value
Age, years 57 (50–65) 70 (65–75) < .001
Male gender, n (%) 85 (85.0%) 51 (50.5%) < .001
Hypertension, n (%) 57 (57.0%) 70 (69.3%) .070
Diabetes, n (%) 28 (23.0%) 21 (20.8%) .234
Smoking, n (%) 23 (25.0%) 7 (6.9%) .001
COPD, n (%) 2 (2.0%) 2 (2.0%) 1.0
PAD, n (%) 5 (5.0%) 8 (7.9%) .400
BMI, kg/m2 25.7 ± 3.6 23.9 ± 2.9 < .001
WBC, 109/L 6.7 (5.5–8.4) 6.5 (5.3–8.0) .383
NEUT, 109/L 4.1 (3.4–5.4) 4.1 (3.4–5.7) .964
LYM, 109/L 1.9 (1.4–2.2) 1.6 (1.2–2.0) .007
NLR 2.3 (1.7–3.3) 2.6 (2.0–3.5) .069
Platelet, 109/L 188 (148–222) 162 (140–210) .061
RDW 12.8 (12.5–13.3) 13.0 (12.6–13.5) .053
Hemoglobin, g/L 135.3 ± 15.4 123.7 ± 15.4 < .001
IL-6, pg/ml 6.6 (3.8–9.2) 8.2 (5.2–14.4) .002
hs-CRP, mg/l 5.7 (1.2–10.1) 6.2 (2.4–14.7) .087
Glucose, mmol/L 5.8 ± 2.8 5.5 ± 1.8 .336
TC, mmol/L 4.0 ± 1.0 3.9 ± 1.0 .552
Triglyceride, mmol/L 1.5 (1.0–2.0) 1.3 (1.0–1.9) .439
HDL-c, mmol/L 1.2 (1.0–1.4) 1.2 (1.1–1.4) .213
LDL-c, mmol/L 2.2 ± 0.7 2.2 ± 0.8 .715
apoB, g/L 0.8 (0.6–1.0) 0.8 (0.6–0.9) .662
apoA1, g/L 1.0 ± 0.2 1.1 ± 0.2 .321
Creatinine, umol/L 68.4 (59.2–79.6) 72.0 (55.4–92.7) .237
eGFR, ml/min 103.9 (86.1–126.9) 69.9 (53.9–88.8) < .001
Albumin, g/L 39.9 (38.4–42.2) 38.1 (36.1–40.5) < .001
Fibrinogen, g/L 3.0 (2.5–3.6) 3.2 (2.7–4.0) .041
D-Dimer, ug/ml 0.3 (0.2–0.4) 0.4 (0.2–0.7) .001
LVEF, % 63.0 (59.0–65.0) 62.0 (50.0–65.0) .050
SS 11.0 (7.0–16.0) 15.0 (9.0–22.0) < .001
SS II 20.8 (17.8–22.9) 32.3 (28.6–38.1) < .001
rSS 2.0 (0–5.4) 4.0 (0–9.0) .161
  1. BMI, Body Mass Index; WBC, white blood cell; NEUT, neutrophil; LYM, lymphocyte; NLR, the neutrophil to the lymphocyte ratio; RDW, red cell distribution width; IL-6, interleukin 6; hs-CRP, high-sensitivity C-reactive protein; TC, total cholesterol; HDL-c, high-density lipoprotein cholesterol; LDL-c, low-density lipoprotein cholesterol; apoB, apolipoprotein B; apoA1, apolipoprotein A1; apoB/apoA1, the apoB to the apoA1 ratio; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; SYNTAX, SYNergy between Percutaneous Coronary Intervention with TAXus and cardiac surgery; SS, SYNTAX score; SS II, SYNTAX score II